{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:03Z","timestamp":1786980543591,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10096-020-03997-3","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T23:36:33Z","timestamp":1596843393000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-2736","authenticated-orcid":false,"given":"Thomas","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-074X","authenticated-orcid":false,"given":"Martin","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"key":"3997_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/bmb\/ldp039","volume":"93","author":"A Lalvani","year":"2010","unstructured":"Lalvani A, Pareek M (2010) A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 93:69\u201384. https:\/\/doi.org\/10.1093\/bmb\/ldp039","journal-title":"Br Med Bull"},{"key":"3997_CR2","doi-asserted-by":"publisher","unstructured":"Pai M, Zwerling A, Menzies D (2008) Systematic review: t-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149:177\u2013184. https:\/\/doi.org\/10.7326\/0003-4819-149-3-200808050-00241","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"3997_CR3","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","volume":"46","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D et al (2015) Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 46:1563\u20131576. https:\/\/doi.org\/10.1183\/13993003.01245-2015","journal-title":"Eur Respir J"},{"key":"3997_CR4","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control, editor (2011) Use of interferon-gamma release assays in support of TB diagnosis: ad hoc scientific panel opinion. [Luxembourg: Publ. Off.]. https:\/\/doi.org\/10.2900\/38588","DOI":"10.2900\/38588"},{"key":"3997_CR5","doi-asserted-by":"publisher","unstructured":"Ringshausen FC, Schablon A, Nienhaus A. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. Journal of occupational medicine and toxicology (London, England) 2012 26;7:6. doi: https:\/\/doi.org\/10.1186\/1745-6673-7-6","DOI":"10.1186\/1745-6673-7-6"},{"key":"3997_CR6","doi-asserted-by":"publisher","unstructured":"Tagmouti S, Slater M, Benedetti A, Kik SV, Banaei N, Cattamanchi A, et al. Reproducibility of interferon gamma (IFN-\u03b3) release assays. A systematic review. Ann Am Thorac Soc 2014;11:1267\u20131276. doi: https:\/\/doi.org\/10.1513\/AnnalsATS.201405-188OC","DOI":"10.1513\/AnnalsATS.201405-188OC"},{"key":"3997_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/JCM.02803-15","volume":"54","author":"N Banaei","year":"2016","unstructured":"Banaei N, Gaur RL, Pai M (2016) Interferon gamma release assays for latent tuberculosis: what are the sources of variability? J Clin Microbiol 54:845\u2013850. https:\/\/doi.org\/10.1128\/JCM.02803-15","journal-title":"J Clin Microbiol"},{"key":"3997_CR8","doi-asserted-by":"crossref","unstructured":"Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, Pasvol G, et al. (2006) Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 1(193):354\u20139. https:\/\/doi.org\/10.1086\/499311","DOI":"10.1086\/499311"},{"key":"3997_CR9","doi-asserted-by":"publisher","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","volume":"4","author":"RN van Zyl-Smit","year":"2009","unstructured":"van Zyl-Smit RN, Zwerling A, Dheda K, Pai M (2009) Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 4:e8517. https:\/\/doi.org\/10.1371\/journal.pone.0008517","journal-title":"PLoS One"},{"key":"3997_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E et al (2017) Official American thoracic society\/infectious diseases society of America\/Centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 64:111\u2013115. https:\/\/doi.org\/10.1093\/cid\/ciw778","journal-title":"Clin Infect Dis"},{"key":"3997_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2307\/2529786","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33:363\u2013374","journal-title":"Biometrics"},{"key":"3997_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.201501-0199OC","volume":"192","author":"TC King","year":"2015","unstructured":"King TC, Upfal M, Gottlieb A, Adamo P, Bernacki E, Kadlecek CP et al (2015) T-SPOT.TB interferon-\u03b3 release assay performance in healthcare worker screening at nineteen U.S. hospitals. Am J Respir Crit Care Med 192:367\u2013373. https:\/\/doi.org\/10.1164\/rccm.201501-0199OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3997_CR13","doi-asserted-by":"publisher","unstructured":"Teranishi S, Kobayashi N, Aoki A, Katakura S, Yamamoto M, Koizumi H et al (2019) Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan. J Infect Chemother. https:\/\/doi.org\/10.1016\/j.jiac.2019.08.006","DOI":"10.1016\/j.jiac.2019.08.006"},{"key":"3997_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","volume":"189","author":"SE Dorman","year":"2014","unstructured":"Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P et al (2014) Interferon-\u03b3 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 189:77\u201387. https:\/\/doi.org\/10.1164\/rccm.201302-0365OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3997_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jim.2004.06.008","volume":"291","author":"S Janetzki","year":"2004","unstructured":"Janetzki S, Schaed S, Blachere NEB, Ben-Porat L, Houghton AN, Panageas KS (2004) Evaluation of Elispot assays: influence of method and operator on variability of results. J Immunol Methods 291:175\u2013183. https:\/\/doi.org\/10.1016\/j.jim.2004.06.008","journal-title":"J Immunol Methods"},{"key":"3997_CR16","doi-asserted-by":"publisher","unstructured":"Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, et al. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC\/SVI). Cancer Immunol Immunother 2008;57:303\u2013315. doi: https:\/\/doi.org\/10.1007\/s00262-007-0380-6","DOI":"10.1007\/s00262-007-0380-6"},{"key":"3997_CR17","doi-asserted-by":"publisher","unstructured":"Tuuminen T, Tavast E, V\u00e4is\u00e4nen R, Himberg J-J, Sepp\u00e4l\u00e4 I. Assessment of imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis. Clin Vaccine Immunol 2010;17:596\u2013601. doi: https:\/\/doi.org\/10.1128\/CVI.00320-09","DOI":"10.1128\/CVI.00320-09"},{"key":"3997_CR18","unstructured":"Oxford Immunotec. T-SPOT.TB test 96-Well Plate Format (TB.200) PACKAGE INSERT [Internet]. 2009 [cited 2012 1]; http:\/\/www.oxfordimmunotec.com"},{"key":"3997_CR19","unstructured":"FDA, U.S. Food and Drug Administration. PM A P070006: FDA summary of safety and effectiveness data [Internet]. FDA, U.S. Food and Drug Administration; 2008. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cftopic\/pma\/pma.cfm?num=p070006"},{"key":"3997_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tube.2017.12.005","volume":"108","author":"K Rego","year":"2018","unstructured":"Rego K, Pereira K, MacDougall J, Cruikshank W (2018) Utility of the T-SPOT\u00ae.TB test\u2019s borderline category to increase test resolution for results around the cut-off point. Tuberculosis (Edinb) 108:178\u2013185. https:\/\/doi.org\/10.1016\/j.tube.2017.12.005","journal-title":"Tuberculosis (Edinb)"},{"key":"3997_CR21","doi-asserted-by":"publisher","unstructured":"Zhang H-C, Ruan Q-L, Wu J, Zhang S, Yu S-L, Wang S, et al. Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China. Int. J Tuberc Lung Dis 2019;23:989\u2013995. doi: https:\/\/doi.org\/10.5588\/ijtld.18.0252","DOI":"10.5588\/ijtld.18.0252"},{"key":"3997_CR22","doi-asserted-by":"publisher","unstructured":"Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A (2006) Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174:831\u2013839. https:\/\/doi.org\/10.1164\/rccm.200511-1783OC","DOI":"10.1164\/rccm.200511-1783OC"},{"key":"3997_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/MMBR.00010-14","volume":"78","author":"NK Dutta","year":"2014","unstructured":"Dutta NK, Karakousis PC (2014) Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev 78:343\u2013371. https:\/\/doi.org\/10.1128\/MMBR.00010-14","journal-title":"Microbiol Mol Biol Rev"},{"key":"3997_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tube.2015.07.002","volume":"95","author":"V Clifford","year":"2015","unstructured":"Clifford V, He Y, Zufferey C, Connell T, Curtis N (2015) Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review. Tuberculosis (Edinb) 95:639\u2013650. https:\/\/doi.org\/10.1016\/j.tube.2015.07.002","journal-title":"Tuberculosis (Edinb)"},{"key":"3997_CR25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/ije\/dyi243","volume":"34","author":"S Perry","year":"2005","unstructured":"Perry S, Parsonnet J (2005) Commentary: H. pylori infection in early life and the problem of imperfect tests. Int J Epidemiol 34:1356\u20131358. https:\/\/doi.org\/10.1093\/ije\/dyi243","journal-title":"Int J Epidemiol"},{"key":"3997_CR26","doi-asserted-by":"publisher","unstructured":"Perry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J (2008) Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 15:425\u2013432. https:\/\/doi.org\/10.1128\/CVI.00398-07","DOI":"10.1128\/CVI.00398-07"},{"key":"3997_CR27","doi-asserted-by":"publisher","unstructured":"Brodhun B, Altmann D, Hauer B, Haas W. Bericht zur Epidemiologie der Tuberkulose in Deutschland f\u00fcr 2017. 2018; www.rki.de\/tuberkulosedoi:https:\/\/doi.org\/10.17886\/rkipubl-2018-002","DOI":"10.17886\/rkipubl-2018-002"},{"key":"3997_CR28","first-page":"1416","volume":"13","author":"DR Bienek","year":"2009","unstructured":"Bienek DR, Chang CK (2009) Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis. Int J Tuberc Lung Dis 13:1416\u20131421","journal-title":"Int J Tuberc Lung Dis"},{"key":"3997_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/07448481.2011.580029","volume":"60","author":"EA Talbot","year":"2012","unstructured":"Talbot EA, Harland D, Wieland-Alter W, Burrer S, Adams LV (2012) Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting. J Am Coll Heal 60:94\u201396. https:\/\/doi.org\/10.1080\/07448481.2011.580029","journal-title":"J Am Coll Heal"},{"key":"3997_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10096-005-1377-8","volume":"24","author":"T Meier","year":"2005","unstructured":"Meier T, Eulenbruch H-P, Wrighton-Smith P, Enders G, Regnath T (2005) Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24:529\u2013536. https:\/\/doi.org\/10.1007\/s10096-005-1377-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3997_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ni1033","volume":"5","author":"PJ Linton","year":"2004","unstructured":"Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5:133\u2013139. https:\/\/doi.org\/10.1038\/ni1033","journal-title":"Nat Immunol"},{"key":"3997_CR32","doi-asserted-by":"publisher","unstructured":"Bae W, Park KU, Song EY, Kim SJ, Lee YJ, Park JS, et al. Comparison of the sensitivity of QuantiFERON-TB gold in-tube and T-SPOT.TB according to patient age. PLoS One 2016;11:e0156917. doi: https:\/\/doi.org\/10.1371\/journal.pone.0156917","DOI":"10.1371\/journal.pone.0156917"},{"issue":"2","key":"3997_CR33","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/bmj.2.5359.720","volume":"21","author":"RN Johnston","year":"1963","unstructured":"Johnston RN, Ritchie RT, Murray IH (1963) Declining tuberculin sensitivity with advancing age. Br Med J 21(2):720\u2013724. https:\/\/doi.org\/10.1136\/bmj.2.5359.720","journal-title":"Br Med J"},{"key":"3997_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/arrd.1964.90.5.707","volume":"90","author":"S Grzybowski","year":"1964","unstructured":"Grzybowski S, Allen EA (1964) The challenge of tuberculosis in decline. A study based on the epidemiology of tuberculosis in Ontario, Canada. Am Rev Respir Dis 90:707\u2013720. https:\/\/doi.org\/10.1164\/arrd.1964.90.5.707","journal-title":"Am Rev Respir Dis"},{"key":"3997_CR35","doi-asserted-by":"publisher","first-page":"e1441","DOI":"10.1371\/journal.pone.0001441","volume":"3","author":"F Karam","year":"2008","unstructured":"Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, LeFevre AM et al (2008) Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV\/AIDS progression. PLoS One 3:e1441. https:\/\/doi.org\/10.1371\/journal.pone.0001441","journal-title":"PLoS One"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03997-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-03997-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03997-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T19:32:16Z","timestamp":1628364736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-03997-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03997-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"18 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"TM had received honoraria from Oxford Immunotec for speaking at symposia and teaching practical T-SPOT.<i>TB<\/i> test processing. ME does not have any conflict of interest. Oxford Immunotec had no role in study design, data collection and analysis, decision to publish or manuscript preparation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of the Landes\u00e4rztekammer Baden-W\u00fcrttemberg approved the study (reference F-2019-059).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No informed consent was required since this was a retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}